Thrainsdottir Soley, Malik Rayez A, Dahlin Lars B, Wiksell Peter, Eriksson Karl F, Rosén Ingmar, Petersson Jesper, Greene Douglas A, Sundkvist Göran
Department of Neurology, University of Lund, Malmö University Hospital, Malmö, Sweden.
Diabetes. 2003 Oct;52(10):2615-22. doi: 10.2337/diabetes.52.10.2615.
To explore whether microangiopathy is associated with disturbed glucose tolerance and peripheral neuropathy, we assessed endoneurial capillary morphology in sural nerve biopsies from men with diabetes, impaired glucose tolerance (IGT), and normal glucose tolerance (NGT). Baseline morphology was related to glucose tolerance and neuropathy at baseline and at follow-up 6 years later. Capillary density (in number per millimeters squared) at baseline was higher in subjects with diabetes (n = 10) compared with those with NGT (n = 5) at follow-up (median [interquartile range]) (86.0 [24.3] vs. 54.9 [17.1]; P = 0.0200) and in those progressing from IGT to diabetes (n = 4) compared with those with persistent IGT (n = 4) (86.7 [25.2] vs. 54.1 [14.6]; P = 0.0433). The capillary luminal area (in micrometers squared) was lower in subjects with NGT progressing to IGT (n = 2) or subjects with IGT progressing to diabetes (n = 3) compared with subjects with constant NGT (n = 6) or constant IGT (n = 4) (11.9 [2.4] vs. 20.8 [7.8]; P = 0.0201). The capillary basement membrane area (in micrometers squared) was increased in patients with peripheral neuropathy (n = 10) compared with those without (n = 7) (114.6 [68.8] vs. 75.3 [28.7]; P = 0.0084). In conclusion, increased capillary density was associated with current or future diabetes, decreased capillary luminal area with future deterioration in glucose tolerance, and increased basement membrane area with peripheral neuropathy.
为探究微血管病变是否与糖耐量异常及周围神经病变相关,我们评估了糖尿病男性、糖耐量受损(IGT)男性及糖耐量正常(NGT)男性腓肠神经活检标本中的神经内膜毛细血管形态。基线形态与基线时及6年后随访时的糖耐量和神经病变相关。随访时,糖尿病患者(n = 10)的基线毛细血管密度(每平方毫米数量)高于糖耐量正常者(n = 5)(中位数[四分位间距])(86.0 [24.3] 对54.9 [17.1];P = 0.0200),从IGT进展为糖尿病者(n = 4)高于持续IGT者(n = 4)(86.7 [25.2] 对54.1 [14.6];P = 0.0433)。糖耐量正常进展为IGT者(n = 2)或IGT进展为糖尿病者(n = 3)的毛细血管腔面积(平方微米)低于糖耐量持续正常者(n = 6)或持续IGT者(n = 4)(11.9 [2.4] 对20.8 [7.8];P = 0.0201)。周围神经病变患者(n = 10)的毛细血管基底膜面积(平方微米)高于无周围神经病变者(n = 7)(114.6 [68.8] 对75.3 [28.7];P = 0.0084)。总之,毛细血管密度增加与当前或未来糖尿病相关,毛细血管腔面积减小与未来糖耐量恶化相关,基底膜面积增加与周围神经病变相关。